Use of (4-alkylpiperazinyl) (phenyl) methanones in the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005240991 (hide)

Owner Samaritan Pharmaceuticals, Inc. Georgetown University

Inventors Lecanu, Laurent; Papadopoulos, Vassilios; Greeson, Janet

Agent Pizzeys

Pub. Number AU-A-2005240991

PCT Pub. Number WO2005/108378

Priority 60/562,643 15.04.04 US

Filing date 12 April 2005

Wipo publication date 17 November 2005

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/108378 Priority application(s): WO2005/108378

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005241000-Process to manufacture luge oil products

2005240983-Latch mechanism guide